Prevagen Research Presented at Healthcare Practitioner Conference
Quincy Bioscience is pleased to announce that Dr. Scott Theirl, a functional neurologist in private practice in Mequon, Wis., is presenting data supporting the use of Prevagen Professional in older adults with mild memory problems at the Integrative Healthcare Symposium – Focus On Brain Health conference on Sept. 19-20 in Hollywood, Fla.
Prevagen Professional is the strongest formula available of the jellyfish protein apoaequorin-containing supplements. Prevagen Professional is available exclusively through healthcare provider offices.
Dr. Theirl is presenting data which demonstrate apoaequorin improves several aspects of cognitive function compared to placebo – such as the ability to learn and recall information, and improve executive function, in 90 days for adults over 40 years old.
The conference, which is a collaboration with the University of Miami, will feature nationally known physicians and researchers sharing leading edge research with healthcare practitioners on providing the best brain health care for their patients.
Scott Theirl, DC, DACNB, FACFN is a graduate of the University of Wisconsin and Logan College of Chiropractic. He holds additional Diplomate certification from the American Chiropractic Neurology Board and is a Fellow of the American College of Functional Neurology. Dr. Theirl has experience lecturing to national patient advocacy groups, educators and professional organizations.
Prevagen® brand supplements have been available for seven years and demand for the products continue to grow as Americans are living longer healthier lives than ever before. Prevagen has helped hundreds of thousands of customers through its nationwide distribution in drugstores, health food stores, and physician offices since the product was launched.
About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wis. focused on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the patented protein apoaequorin, which is breaking new ground in the area of brain health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.